S. Chiara

1.3k total citations
36 papers, 828 citations indexed

About

S. Chiara is a scholar working on Oncology, Reproductive Medicine and Surgery. According to data from OpenAlex, S. Chiara has authored 36 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 13 papers in Reproductive Medicine and 11 papers in Surgery. Recurrent topics in S. Chiara's work include Ovarian cancer diagnosis and treatment (13 papers), Colorectal Cancer Treatments and Studies (12 papers) and Colorectal and Anal Carcinomas (7 papers). S. Chiara is often cited by papers focused on Ovarian cancer diagnosis and treatment (13 papers), Colorectal Cancer Treatments and Studies (12 papers) and Colorectal and Anal Carcinomas (7 papers). S. Chiara collaborates with scholars based in Italy, United States and Switzerland. S. Chiara's co-authors include R. Rosso, Pierfranco Conté, Milena Bruzzone, Alfredo Falcone, Fotios Loupakis, Lorenzo Fornaro, Gianluca Masi, A. Rubagotti, Cristina Granetto and Chiara Cremolini and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

S. Chiara

34 papers receiving 803 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Chiara Italy	12	579	326	218	173	158	36	828
Stacy Nerenstone United States	7	122 0.2×	237 0.7×	281 1.3×	81 0.5×	146 0.9×	9	589
Chiung‐Ru Lai Taiwan	13	173 0.3×	199 0.6×	130 0.6×	64 0.4×	75 0.5×	37	603
Ho-Kyung Chun South Korea	13	230 0.4×	224 0.7×	56 0.3×	116 0.7×	37 0.2×	31	562
Chukwuemeka Ihemelandu United States	16	255 0.4×	472 1.4×	210 1.0×	109 0.6×	22 0.1×	28	778
Michele Valente Italy	19	149 0.3×	121 0.4×	302 1.4×	125 0.7×	39 0.2×	61	820
P. Comella Italy	19	656 1.1×	143 0.4×	37 0.2×	378 2.2×	82 0.5×	65	829
Saifee Mullamitha United Kingdom	8	226 0.4×	61 0.2×	76 0.3×	75 0.4×	79 0.5×	32	467
María Jesús Rubio Spain	16	180 0.3×	344 1.1×	506 2.3×	69 0.4×	17 0.1×	48	693
D. Smaniotto Italy	19	361 0.6×	486 1.5×	209 1.0×	265 1.5×	23 0.1×	50	1.0k
Michael B. Campion United States	17	287 0.5×	379 1.2×	35 0.2×	305 1.8×	59 0.4×	33	715

Countries citing papers authored by S. Chiara

Since Specialization

Citations

This map shows the geographic impact of S. Chiara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Chiara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Chiara more than expected).

Fields of papers citing papers by S. Chiara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Chiara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Chiara. The network helps show where S. Chiara may publish in the future.

Co-authorship network of co-authors of S. Chiara

This figure shows the co-authorship network connecting the top 25 collaborators of S. Chiara. A scholar is included among the top collaborators of S. Chiara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Chiara. S. Chiara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chiara, S., et al.. (2025). Development and evaluation of a novel capillary blood collection method for decentralized therapeutic drug monitoring using the True Dose kit. Scientific Reports. 15(1). 33331–33331.

Chiara, S., et al.. (2024). Recurrent benign fibrous histiocytoma of the bone benefits from denosumab followed by malignant transformation: a case report. Skeletal Radiology. 53(11). 2537–2543.

Masi, Gianluca, Lisa Salvatore, Luca Boni, et al.. (2015). Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial. Annals of Oncology. 26(4). 724–730. 125 indexed citations

Cremolini, Chiara, Fotios Loupakis, Daniele Rossini, et al.. (2014). Folfoxiri with or Without Bevacizumab (Bev) As First-Line Treatment of Metastatic Colorectal Cancer (Mcrc): a Propensity Score-Based Analysis. Annals of Oncology. 25. iv175–iv175. 2 indexed citations

Masi, Gianluca, Fotios Loupakis, Lorenzo Fornaro, et al.. (2010). Randomized Trial of Two Induction Chemotherapy Regimens in Metastatic Colorectal Cancer: An Updated Analysis. JNCI Journal of the National Cancer Institute. 103(1). 21–30. 137 indexed citations

Vasile, Enrico, Gianluca Masi, Lorenzo Fornaro, et al.. (2009). A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer. British Journal of Cancer. 100(11). 1720–1724. 31 indexed citations

Bengala, Carmelo, Stefania Bettelli, Federica Bertolini, et al.. (2008). Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer. Annals of Oncology. 20(3). 469–474. 72 indexed citations

Fornaro, Lorenzo, Gianluca Masi, Fotios Loupakis, et al.. (2008). A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer. Cancer Chemotherapy and Pharmacology. 63(5). 965–969. 13 indexed citations

Krengli, Marco, Marco Dominietto, S. Chiara, et al.. (2005). Study of Lymphatic Drainage by SPECT-CT Fusion Images for Pelvic Irradiation of Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 63. S305–S305. 2 indexed citations

10.

Paoli, Antonino De, S. Chiara, Gabriele Luppi, et al.. (2005). Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study. Annals of Oncology. 17(2). 246–251. 106 indexed citations

11.

Chiara, S., et al.. (1997). Hand-foot syndrome induced by high-dose, short-term, continuous 5-fluorouracil infusion. European Journal of Cancer. 33(6). 967–969. 33 indexed citations

12.

Chiara, S., Rita Lionetto, Elisabetta Campora, et al.. (1995). Long-term prognosis following macroscopic complete response at second-look laparotomy in advanced ovarian cancer patients treated with platinum-based chemotherapy. European Journal of Cancer. 31(3). 296–301. 18 indexed citations

13.

Alama, Angela, S. Chiara, Domenico Franco Merlo, et al.. (1994). Tumour kinetics, response to chemotherapy and survival in primary ovarian cancer. European Journal of Cancer. 30(4). 449–452. 4 indexed citations

14.

Gadducci, Angiolo, I. Brunetti, Marco Bruzzone, et al.. (1992). Cisplatin-based combination chemotherapy with or without doxorubicin in advanced epithelial ovarian cancer: 8-year update of a randomized multicentric clinical trial. The Gruppo Oncologico Nord Ovest (GONO).. PubMed. 13(1 Suppl). 36–9. 3 indexed citations

15.

Chiara, S., Serafina Mammoliti, Cristina Oliva, et al.. (1991). Adjuvant cisplatin-based chemotherapy for stage I and II ovarian cancer: a 7-year experience. European Journal of Cancer and Clinical Oncology. 27(10). 1211–1215. 8 indexed citations

16.

Conté, Pierfranco, Milena Bruzzone, F Carnino, et al.. (1991). Carboplatin, doxorubicin, and cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide: a randomized trial in stage III-IV epithelial ovarian carcinoma.. Journal of Clinical Oncology. 9(4). 658–663. 49 indexed citations

17.

Campora, Elisabetta, Editta Baldini, A. Rubagotti, et al.. (1990). Double-Blind Randomized Trial of Lorazepam versus Placebo with Methylprednisolone for Control of Emesis Due to Non-Cisplatin Containing Chemotherapy. Journal of Chemotherapy. 2(5). 336–339. 5 indexed citations

18.

Conté, Pierfranco, Angela Alama, A. Rubagotti, et al.. (1989). Cell kinetics in ovarian cancer. Relationship to clinicopathologic features, responsiveness to chemotherapy, and survival. Cancer. 64(6). 1188–1191. 20 indexed citations

19.

Chiara, S., Pierfranco Conté, Milena Bruzzone, et al.. (1987). Cisplatin and cyclophosphamide in early epithelial ovarian carcinoma.. PubMed. 6(2 Suppl). 380–1. 3 indexed citations

20.

Conté, Pierfranco, Milena Bruzzone, S. Chiara, et al.. (1986). A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer.. Journal of Clinical Oncology. 4(6). 965–971. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact